APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Digoxin

Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Digoxin is used chronically in the therapy of cardiac arrhythmias, especially atrial fibrillation, atrial flutter and heart failure. It is the most effective medicine for the treatment of heart failure, and a third line medication in the treatment of irregular heartbeat. It is normally administered orally as tabs but can also be given intravenously under urgent circumstances.

Types
Purity Above 98% · Purity Below 98%
Applications
Tablet Product · Injection Product

5 editions20 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: DigoxinCompare research options for Digoxin
APO Research, Inc.